Skip to content
10-Q

Quarterly Report

ROIVANT SCIENCES LTD. ROIV

0001140361-25-030001

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Aug 6, 2025 682.88M sh
Shares Diluted Q1 2025 · Jun 30, 2025 680.29M sh
Shares Diluted Q1 2025 · Jun 30, 2024 781.63M sh
Stock Repurchased Q1 2025 · Jun 30, 2025 $208.29M
Stock Repurchased Q1 2025 · Jun 30, 2024 $648.39M
Capex Q1 2025 · Jun 30, 2025 $4.04M
Capex Q1 2025 · Jun 30, 2024 $965K
Operating Cash Flow Q1 2025 · Jun 30, 2025 −$204.38M
Operating Cash Flow Q1 2025 · Jun 30, 2024 −$192.83M
Cash And Equivalents Q1 2025 · Jun 30, 2025 $1.24B
Cash And Equivalents Q1 2025 · Mar 31, 2025 $2.72B
Stockholders Equity Q1 2025 · Jun 30, 2025 $4.35B
Stockholders Equity Q1 2025 · Mar 31, 2025 $4.69B
Current Liabilities Q1 2025 · Jun 30, 2025 $113.87M
Current Liabilities Q1 2025 · Mar 31, 2025 $149.41M
Total Liabilities Q1 2025 · Jun 30, 2025 $216.7M
Total Liabilities Q1 2025 · Mar 31, 2025 $249.74M
Current Assets Q1 2025 · Jun 30, 2025 $4.62B
Current Assets Q1 2025 · Mar 31, 2025 $5B
Total Assets Q1 2025 · Jun 30, 2025 $5.03B
Total Assets Q1 2025 · Mar 31, 2025 $5.44B
Eps Diluted Q1 2025 · Jun 30, 2025 −$0.33
Eps Diluted Q1 2025 · Jun 30, 2024 $0.12
Eps Basic Q1 2025 · Jun 30, 2025 −$0.33
Eps Basic Q1 2025 · Jun 30, 2024 $0.13
Rd Expense Q1 2025 · Jun 30, 2025 $152.92M
Rd Expense restated Q1 2025 · Jun 30, 2024 $120.51M
Net Income Q1 2025 · Jun 30, 2025 −$223.36M
Net Income Q1 2025 · Jun 30, 2024 $95.3M
Operating Income Q1 2025 · Jun 30, 2025 −$284.92M
Operating Income restated Q1 2025 · Jun 30, 2024 −$102.24M
Revenue Q1 2025 · Jun 30, 2025 $2.17M
Revenue restated Q1 2025 · Jun 30, 2024 $7.99M